TNF-alpha suppresses bone sialoprotein (BSP) expression in ROS17/2.8 cells

Area of Science:

• Molecular Biology
• Biochemistry
• Cell Biology

Background:

• Tumor necrosis factor-alpha (TNF-alpha) is a key inflammatory mediator implicated in diseases that affect bone metabolism.
• TNF-alpha is known to inhibit bone formation and promote bone resorption.
• Bone sialoprotein (BSP) is crucial for bone mineralization and its expression is restricted to differentiated cells.

Purpose of the Study:

• To elucidate the molecular mechanisms by which TNF-alpha suppresses bone formation.
• To investigate the effect of TNF-alpha on Bone sialoprotein (BSP) gene expression in osteoblasts.

Main Methods:

• Treatment of rat osteosarcoma ROS 17/2.8 cells with TNF-alpha.
• Analysis of BSP mRNA levels using quantitative methods.
• Reporter gene assays with BSP promoter constructs.
• Site-directed mutagenesis of the BSP promoter.
• Gel mobility shift assays to study DNA-protein interactions.

Main Results:

• TNF-alpha significantly reduced BSP mRNA levels in ROS 17/2.8 cells.
• The inhibitory effect of TNF-alpha on BSP expression was mediated by a cAMP response element (CRE) in the proximal promoter region (-75 to -68).
• TNF-alpha-induced suppression of BSP transcription involved a tyrosine kinase-dependent pathway generating reactive oxygen species, as indicated by inhibition with N-acetylcysteine (NAC) and herbimycin A (HA).
• Gel mobility shift assays confirmed decreased binding of nuclear proteins to the CRE sequence upon TNF-alpha stimulation, an effect reversed by NAC and HA.

Conclusions:

• TNF-alpha suppresses BSP gene transcription through a tyrosine kinase-dependent pathway.
• Reactive oxygen species play a role in TNF-alpha-mediated inhibition of BSP expression.
• The cAMP response element (CRE) in the BSP promoter is a critical target for TNF-alpha-induced gene regulation in bone cells.